Hypothesis

Aging is not a passive byproduct of declining selection but an actively maintained program that limits mTORC1 activity after reproduction to trigger a low‑grade, sterile inflammation that benefits close kin by reducing competition for scarce resources. This program is orchestrated by a conserved epigenetic switch that silences the mTORC1 pathway in somatic tissues once germline signaling wanes, thereby coupling reproductive cessation to a physiologically adaptive senescent state.

Mechanistic rationale

• Germline‑somatic signaling: In many model organisms, germline-derived signals (e.g., IGF‑like peptides) keep somatic mTORC1 active during reproductive life. When germline activity declines, these signals drop, allowing a DNA methyltransferase complex (DNMT3A/3B) to methylate the promoter of Raptor, a core mTORC1 subunit. This epigenetic lock reduces mTORC1 signaling, a change observed in long‑lived species such as naked mole‑rats and bats (2).
• mTORC1 attenuation and inflammasome priming: Lower mTORC1 activity shifts cellular metabolism toward autophagy and increases NAD⁺ levels, which activate SIRT1. SIRT1 deacetylates NLRP3, priming the inflammasome for a controlled release of IL‑1β and IL‑18. This sterile, transient inflammation stimulates hematopoietic stem cells in neighboring juveniles, enhancing their stress resistance and survival without causing pathology.
• Kin‑selection benefit: By mildly activating innate immunity in older individuals, the host creates a local cytokine milieu that improves wound healing and pathogen resistance in nearby young relatives, offsetting the individual’s loss of future reproduction. The net inclusive fitness gain mirrors predictions from models where senescence accelerates generational turnover (3).

Testable predictions

1. Epigenetic mark: In reproductively aged wild‑type mice, the Raptor promoter will show increased CpG methylation compared with sexually mature counterparts; methylation levels will correlate with circulating IL‑1β levels.
2. Causal link: Pharmacological inhibition of DNMTs in aged mice will prevent Raptor methylation, maintain mTORC1 activity, blunt the age‑associated inflammasome activation, and reduce survival advantage of co‑housed juvenile littermates under resource‑limited conditions.
3. Cross‑species comparison: Species with negligible senescence (e.g., Brandt’s bat) will exhibit stable Raptor promoter methylation status across the lifespan, whereas short‑lived species with high extrinsic mortality will display age‑dependent methylation gain.
4. Human relevance: Peripheral blood mononuclear cells from post‑menopausal women will show higher RPTOR methylation and elevated NLRP3 activity than pre‑menopausal age‑matched controls; modulation of DNMT activity ex vivo will inversely affect inflammasome readouts.

Experimental approach

• Mouse model: Use a tamoxifen‑inducible, somatic‑specific DNMT3A/3B knockout (Dst‑CreERT2; Dnmt3a^fl/fl; Dnmt3b^fl/fl) to test prediction 2. Measure mTORC1 signaling (p‑S6K), inflammasome activation (caspase‑1 p20, IL‑1β), and competitive fitness of juveniles housed with aged mutants versus controls under 30 % caloric restriction.
• Comparative epigenomics: Perform bisulfite sequencing of Raptor promoters from liver tissue of bat, mouse, and human donors across age ranges to assess prediction 3.
• Human cohort: Analyze methylation and inflammasome markers in the Women’s Health Initiative dataset; apply Mendelian randomization using DNMT‑related SNPs to evaluate causality for prediction 4.

Implications

If validated, this hypothesis reframes senescence as a programmable, altruistic trait that can be tuned rather than abolished. Interventions would aim to modulate the epigenetic‑mTORC1‑inflammasome axis to preserve the beneficial kin‑supportive signal while mitigating maladaptive chronic inflammation, aligning longevity medicine with the evolutionary logic that shaped aging.